The issue of whether increased fibrous cap thickness is related to reduced EndMT versus a specific effect of HDAC9 is the subject of ongoing studies in our laboratory; however, these findings are consistent with prior research showing that a reduction in EndMT is associated with a beneficial effect on atherosclerosis (13, 52) and a more stable plaque phenotype in humans (12). Here, HDAC9 is linked to atherosclerosis.